(0.19%) 5 141.00 points
(0.18%) 38 510 points
(0.26%) 17 893 points
(-0.87%) $83.12
(1.92%) $1.960
(-0.03%) $2 346.40
(0.08%) $27.56
(0.63%) $927.95
(-0.25%) $0.932
(-0.24%) $11.00
(-0.30%) $0.798
(1.16%) $92.94
-1.14% INR 309.00
Live Chart Being Loaded With Signals
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies...
Stats | |
---|---|
Tagesvolumen | 180 400 |
Durchschnittsvolumen | 337 307 |
Marktkapitalisierung | 38.10B |
EPS | INR0 ( 2024-02-08 ) |
Nächstes Ertragsdatum | ( INR1.000 ) 2024-05-27 |
Last Dividend | INR0.600 ( 2023-09-18 ) |
Next Dividend | INR0 ( N/A ) |
P/E | 53.18 |
ATR14 | INR0.294 (0.10%) |
Volumen Korrelation
Hikal Limited Korrelation
10 Am meisten positiv korreliert | |
---|---|
NECLIFE.NS | 0.933 |
BIOFILCHEM.NS | 0.933 |
NOVARTIND.NS | 0.932 |
PCJEWELLER.NS | 0.932 |
MAHLOG.NS | 0.928 |
SYNCOMF.NS | 0.927 |
ICICIGI.NS | 0.926 |
RADIOCITY.NS | 0.924 |
BASF.NS | 0.921 |
ARIHANTCAP.NS | 0.92 |
10 Am meisten negativ korreliert | |
---|---|
JINDCOT.NS | -0.929 |
SIEMENS.NS | -0.91 |
BLUESTARCO.NS | -0.91 |
NEWGEN.NS | -0.909 |
MAFANG.NS | -0.9 |
IRISDOREME.NS | -0.9 |
CIGNITITEC.NS | -0.9 |
RADAAN.NS | -0.899 |
ITC.NS | -0.899 |
KPITTECH.NS | -0.895 |
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Hikal Limited Korrelation - Währung/Rohstoff
Hikal Limited Finanzdaten
Annual | 2022 |
Umsatz: | INR20.05B |
Bruttogewinn: | INR8.98B (44.78 %) |
EPS: | INR6.36 |
FY | 2022 |
Umsatz: | INR20.05B |
Bruttogewinn: | INR8.98B (44.78 %) |
EPS: | INR6.36 |
FY | 2022 |
Umsatz: | INR19.26B |
Bruttogewinn: | INR8.93B (46.35 %) |
EPS: | INR13.02 |
FY | 2021 |
Umsatz: | INR17.07B |
Bruttogewinn: | INR7.70B (45.13 %) |
EPS: | INR10.80 |
Financial Reports:
No articles found.
Hikal Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0.400 (N/A) |
INR0 (N/A) |
INR0.600 (N/A) |
INR0 (N/A) |
INR0.600 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | INR0.400 | 2002-07-11 |
Last Dividend | INR0.600 | 2023-09-18 |
Next Dividend | INR0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 39 | -- |
Total Paid Out | INR19.08 | -- |
Avg. Dividend % Per Year | 0.37% | -- |
Score | 1.94 | -- |
Div. Sustainability Score | 0.699 | |
Div.Growth Potential Score | 1.972 | |
Div. Directional Score | 1.335 | -- |
Year | Amount | Yield |
---|---|---|
2002 | INR0 | 0.00% |
2003 | INR0 | 0.00% |
2004 | INR0 | 0.00% |
2005 | INR0 | 0.00% |
2006 | INR0 | 0.00% |
2007 | INR0 | 0.00% |
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR0.967 | 0.57% |
2019 | INR1.200 | 0.77% |
2020 | INR1.200 | 1.03% |
2021 | INR2.00 | 1.20% |
2022 | INR1.600 | 0.30% |
2023 | INR1.200 | 0.30% |
2024 | INR0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
UBL.NS | Dividend Junior | 2023-08-03 | Annually | 17 | 0.27% | |
POLYCAB.NS | Dividend Knight | 2023-06-21 | Annually | 6 | 0.50% | |
JSL.NS | Dividend Junior | 2023-09-15 | Sporadic | 22 | 0.26% | |
DLF.NS | Dividend Junior | 2023-07-28 | Annually | 18 | 0.60% | |
AARON.NS | Dividend Junior | 2023-08-28 | Sporadic | 5 | 0.36% | |
SOUTHBANK.NS | Dividend Junior | 2023-08-17 | Sporadic | 25 | 0.42% | |
MONARCH.NS | Dividend Junior | 2023-09-14 | Annually | 3 | 0.20% | |
HERANBA.NS | Dividend Junior | 2023-08-17 | Annually | 4 | 0.20% | |
BHEL.NS | Dividend Junior | 2023-08-11 | Annually | 21 | 0.26% | |
RAMCOIND.NS | Dividend Junior | 2023-08-02 | Annually | 23 | 0.32% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0397 | 1.500 | 9.21 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | 0.0629 | 1.500 | -0.413 | -0.619 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 2.77 | 1.000 | -0.0850 | -0.0850 | [3 - 30] |
operatingCashFlowPerShareTTM | 18.18 | 2.00 | 3.94 | 7.88 | [0 - 30] |
freeCashFlowPerShareTTM | 18.18 | 2.00 | 0.908 | 1.817 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.467 | 1.000 | 5.55 | 5.55 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0831 | 1.000 | -0.338 | -0.338 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | 0.699 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 53.60 | 1.000 | 4.69 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0629 | 2.50 | -0.265 | -0.619 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 18.18 | 2.00 | 3.94 | 1.817 | [0 - 30] |
dividendYielPercentageTTM | 0.385 | 1.500 | 0.365 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 18.18 | 2.00 | 3.94 | 7.88 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -1.048 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.124 | 1.000 | 9.39 | 0 | [0.1 - 0.5] |
Total Score | 1.972 |
Hikal Limited
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal healthcare, biotech, crop protection, and specialty chemicals companies. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredient (APIs). The Crop Protection segment manufactures pesticides and herbicides. The company collaborates with other companies and offer solutions in contract research, custom synthesis, and custom manufacturing of intermediates and APIs. It also provides specialty biocides and antimicrobial actives, as well as additives for leather, paint coatings, paper, water treatment, personal care, building materials, and textile industries. The company was incorporated in 1988 and is headquartered in Navi Mumbai, India.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.